The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Автор: | Jackson, M |
---|---|
Інші автори: | Vallis, K |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
2013
|
Предмети: |
Схожі ресурси
Схожі ресурси
-
Selective targeting of homologous recombination deficiency
за авторством: Zimmer, J
Опубліковано: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
за авторством: Albukhari, A
Опубліковано: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
за авторством: Albukhari, A
Опубліковано: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
за авторством: Potter, M
Опубліковано: (2014) -
Radiopharmaceutical Validation for Clinical Use
за авторством: Charles A. Kunos, та інші
Опубліковано: (2021-03-01)